Pravastatin-induced improvement in coronary reactivity and circulating ATP and ADP levels in young adults with type 1 diabetes

Aims: Extracellular ATP and ADP regulate diverse inflammatory, prothrombotic and vasoactive responses in the vasculature. Statins have been shown to modulate their signaling pathways in vitro. We hypothesized that altered intravascular nucleotide turnover modulates vasodilation in patients with type 1 diabetes (T1DM), and this can be partly restored with pravastatin therapy. Methods: In this randomized double blind study, plasma ATP and ADP levels and echocardiography-derived coronary flow velocity response to cold pressor test (CPT) were concurrently assessed in 42 normocholesterolemic patients with T1DM (age 30 ± 6 years, LDL cholesterol 2.5 ± 0.6 mmol/L) before and after four-month treatment with pravastatin 40 mg/day or placebo (n = 22 and n = 20, respectively), and in 41 healthy control subjects. Results: Compared to controls, T1DM patients had significantly higher concentrations of ATP (p < 0.01) and ADP (p < 0.01) and these levels were partly restored after treatment with pravastatin (p = 0.002 and p = 0.007, respectively), but not after placebo (p = 0.06 and p = 0.14, respectively). Coronary flow velocity acceleration was significantly lower in T1DM patients compared to control subjects, and it increased from pre- to post-intervention in the pravastatin (p = 0.02), but not in placebo group (p = 0.15). Conclusions: Pravastatin treatment significantly reduces circulating ATP and ADP levels of T1DM patients, and concurrently improves coronary flow response to CPT. This study provides a novel insight in purinergic mechanisms involved in pleiotropic effects of pravastatin.

[1]  G. Scheffer,et al.  Upregulation of Ecto-5′-Nucleotidase by Rosuvastatin Increases the Vasodilator Response to Ischemia , 2010, Hypertension.

[2]  T. Kiviniemi.  Assessment of coronary blood flow and the reactivity of the microcirculation non‐invasively with transthoracic echocardiography , 2008, Clinical physiology and functional imaging.

[3]  G. Burnstock,et al.  P2 receptors in cardiovascular regulation and disease , 2007, Purinergic Signalling.

[4]  B. Uretsky,et al.  Pretreatment with statins may reduce cardiovascular morbidity and mortality after elective surgery and percutaneous coronary intervention: clinical evidence and possible underlying mechanisms. , 2007, American heart journal.

[5]  S. Mortensen,et al.  Intravascular ADP and soluble nucleotidases contribute to acute prothrombotic state during vigorous exercise in humans , 2007, The Journal of physiology.

[6]  O. Raitakari,et al.  Vasodilation of epicardial coronary artery can be measured with transthoracic echocardiography. , 2007, Ultrasound in medicine & biology.

[7]  M. Amrani,et al.  A Novel Role of Extracellular Nucleotides in Valve Calcification: A Potential Target for Atorvastatin , 2006, Circulation.

[8]  J. Molkentin,et al.  High Glucose Activates Nuclear Factor of Activated T Cells in Native Vascular Smooth Muscle , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[9]  S. Robson,et al.  Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. , 2005, Seminars in thrombosis and hemostasis.

[10]  M. Hori,et al.  Optimal Windows of Statin Use for Immediate Infarct Limitation: 5′-Nucleotidase as Another Downstream Molecule of Phosphatidylinositol 3-Kinase , 2004, Circulation.

[11]  O. Raitakari,et al.  Effect of Pravastatin on Low-Density Lipoprotein Oxidation and Myocardial Perfusion in Young Adults With Type 1 Diabetes , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[12]  T. Lehtimäki,et al.  Endothelial Dysfunction and Increased Arterial Intima-Media Thickness in Children With Type 1 Diabetes , 2004, Circulation.

[13]  K. Jacobson,et al.  Coordinated Adenine Nucleotide Phosphohydrolysis and Nucleoside Signaling in Posthypoxic Endothelium , 2003, The Journal of experimental medicine.

[14]  S. Jalkanen,et al.  The evidence for two opposite, ATP-generating and ATP-consuming, extracellular pathways on endothelial and lymphoid cells. , 2002, The Biochemical journal.

[15]  C. Flores,et al.  Inhibition of Nitrobenzylthioinosine-Sensitive Adenosine Transport by Elevated d-Glucose Involves Activation of P2Y2 Purinoceptors in Human Umbilical Vein Endothelial Cells , 2002, Circulation research.

[16]  J. Michel,et al.  Lovastatin Enhances Ecto-5′-Nucleotidase Activity and Cell Surface Expression in Endothelial Cells: Implication of Rho-Family GTPases , 2002, Circulation research.

[17]  A. Szczeklik,et al.  Comparison of the Effect of Verapamil and Propranolol on Response of Coronary Vasomotion to Cold Pressor Test in Symptomatic Patients with Hypertrophic Cardiomyopathy , 2000, Cardiovascular Drugs and Therapy.

[18]  G. Burnstock,et al.  Effect of shear stress on the release of soluble ecto‐enzymes ATPase and 5′‐nucleotidase along with endogenous ATP from vascular endothelial cells , 2000, British journal of pharmacology.

[19]  G Burnstock,et al.  Receptors for purines and pyrimidines. , 1998, Pharmacological reviews.

[20]  G. Burnstock,et al.  Steady-state binding of [3H]ATP to rat liver plasma membranes and competition by various purinergic agonists and antagonists. , 1998, Biochimica et biophysica acta.

[21]  U. Laufs,et al.  Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. , 1998, Circulation.

[22]  T. Lehtimäki,et al.  Coronary Flow Reserve Is Reduced in Young Men With IDDM , 1998, Diabetes.

[23]  P. Groop,et al.  Hyperreactivity to nitrovasodilators in forearm vasculature is related to autonomic dysfunction in insulin-dependent diabetes mellitus. , 1997, Circulation.

[24]  S. Jalkanen,et al.  Impaired ATP-induced coronary blood flow and diminished aortic NTPDase activity precede lesion formation in apolipoprotein E-deficient mice. , 2012, The American journal of pathology.

[25]  M. Bours,et al.  Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. , 2006, Pharmacology & therapeutics.

[26]  D. Kereiakes,et al.  Endothelial dysfunction. , 2003, Circulation.